Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-13 Option Award |
2024-06-13 6:23 pm |
N/A 2034-06-12 |
eFFECTOR Therapeutics Inc. | EFTR | Harrington-Smith Kristen Director |
800 | $0 | 800 (Direct) |
View |
| 2024-02-19 Option Award |
2024-02-21 5:20 pm |
N/A 2034-02-18 |
eFFECTOR Therapeutics Inc. | EFTR | Harrington-Smith Kristen Director |
2,000 | $0 | 2,000 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-22 8:12 pm |
N/A 2033-06-21 |
eFFECTOR Therapeutics Inc. | EFTR | Harrington-Smith Kristen Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-01-20 Option Award |
2023-01-24 4:13 pm |
N/A 2033-01-19 |
eFFECTOR Therapeutics Inc. | EFTR | Harrington-Smith Kristen Director |
28,125 | $0 | 28,125 (Direct) |
View |
| 2022-11-15 Exercise |
2022-11-18 5:31 pm |
2022-11-15 N/A |
ImmunoGen Inc. | IMGN | Harrington-Smith Kristen SVP & CHIEF COMMERCIAL OFFICER |
25,000 | $0 | 75,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 6:46 pm |
N/A 2032-06-08 |
eFFECTOR Therapeutics Inc. | EFTR | Harrington-Smith Kristen Director |
13,333 | $0 | 13,333 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 6:26 pm |
N/A 2032-02-14 |
eFFECTOR Therapeutics Inc. | EFTR | Harrington-Smith Kristen Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-11-15 Option Award |
2021-11-17 4:14 pm |
2022-11-15 2032-11-15 |
ImmunoGen Inc. | IMGN | Harrington-Smith Kristen SVP & Chief Commercial Officer |
450,000 | $5.68 | 525,000 (Direct) |
View |
| 2021-11-15 Option Award |
2021-11-17 4:14 pm |
2022-11-15 N/A |
ImmunoGen Inc. | IMGN | Harrington-Smith Kristen SVP & Chief Commercial Officer |
75,000 | $0 | 525,000 (Direct) |
View |